These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 16115953)

  • 1. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.
    Biliran H; Wang Y; Banerjee S; Xu H; Heng H; Thakur A; Bollig A; Sarkar FH; Liao JD
    Clin Cancer Res; 2005 Aug; 11(16):6075-86. PubMed ID: 16115953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
    Yan LH; Wang XT; Yang J; Lian C; Kong FB; Wei WY; Luo W; Xiao Q; Xie YB
    World J Gastroenterol; 2013 Jul; 19(26):4155-65. PubMed ID: 23864778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 and pancreatic carcinoma: a proliferative agonist and chemotherapeutic antagonist.
    Diehl JA; Benzeno S
    Clin Cancer Res; 2005 Aug; 11(16):5665-7. PubMed ID: 16115900
    [No Abstract]   [Full Text] [Related]  

  • 5. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells.
    Wang Z; Zhang Y; Li Y; Banerjee S; Liao J; Sarkar FH
    Mol Cancer Ther; 2006 Mar; 5(3):483-93. PubMed ID: 16546962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
    Tan ST; Liu SY; Wu B
    Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells.
    Wang J; Wang Q; Cui Y; Liu ZY; Zhao W; Wang CL; Dong Y; Hou L; Hu G; Luo C; Chen J; Lu Y
    J Neurooncol; 2012 Feb; 106(3):473-84. PubMed ID: 21912938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer.
    Ge J; Ge C
    Virchows Arch; 2019 Jan; 474(1):59-69. PubMed ID: 30267303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1.
    Yde CW; Issinger OG
    Int J Oncol; 2006 Dec; 29(6):1397-404. PubMed ID: 17088977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Cao LP; Song JL; Yi XP; Li YX
    Oncol Rep; 2013 Apr; 29(4):1659-65. PubMed ID: 23354694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA].
    Kong R; Sun B; Wang SJ; Pan SH; Wang G; Chen H; Xue DB; Jiang HC
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):128-33. PubMed ID: 20302733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.
    Wang Z; Zhang Y; Banerjee S; Li Y; Sarkar FH
    Cancer; 2006 Jun; 106(11):2503-13. PubMed ID: 16628653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
    Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
    Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
    Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
    Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.
    Hasan R; Chauhan SS; Sharma R; Ralhan R
    World J Gastroenterol; 2012 Aug; 18(31):4127-35. PubMed ID: 22919244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3.
    Tan J; Zhou X; Zhu H
    Exp Clin Transplant; 2012 Aug; 10(4):386-93. PubMed ID: 22757972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
    Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
    PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.